These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 3787261)

  • 1. Catalytic antibodies.
    Tramontano A; Janda KD; Lerner RA
    Science; 1986 Dec; 234(4783):1566-70. PubMed ID: 3787261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transition state docking: a probe for noncovalent catalysis in biological systems. Application to antibody-catalyzed ester hydrolysis.
    Tantillo DJ; Houk KN
    J Comput Chem; 2002 Jan; 23(1):84-95. PubMed ID: 11913392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reactive immunization.
    Wirsching P; Ashley JA; Lo CH; Janda KD; Lerner RA
    Science; 1995 Dec; 270(5243):1775-82. PubMed ID: 8525366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chemical reactivity at an antibody binding site elicited by mechanistic design of a synthetic antigen.
    Tramontano A; Janda KD; Lerner RA
    Proc Natl Acad Sci U S A; 1986 Sep; 83(18):6736-40. PubMed ID: 3462723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. At the crossroads of chemistry and immunology: catalytic antibodies.
    Lerner RA; Benkovic SJ; Schultz PG
    Science; 1991 May; 252(5006):659-67. PubMed ID: 2024118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficient and selective p-nitrophenyl-ester-hydrolyzing antibodies elicited by a p-nitrobenzyl phosphonate hapten.
    Tawfik DS; Lindner AB; Chap R; Eshhar Z; Green BS
    Eur J Biochem; 1997 Mar; 244(2):619-26. PubMed ID: 9119032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Catalytic antibodies: generation of a new class of protein catalysts exploiting the immune system].
    Fujii I
    Yakugaku Zasshi; 1996 Aug; 116(8):606-21. PubMed ID: 8831262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catalytic antibodies hydrolysing organophosphorus esters.
    Brimfield AA; Lenz DE; Maxwell DM; Broomfield CA
    Chem Biol Interact; 1993 Jun; 87(1-3):95-102. PubMed ID: 8344006
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Directed evolution governed by controlling the molecular recognition between an abzyme and its haptenic transition-state analog.
    Takahashi-Ando N; Kakinuma H; Fujii I; Nishi Y
    J Immunol Methods; 2004 Nov; 294(1-2):1-14. PubMed ID: 15604011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic antibodies with lipase activity and R or S substrate selectivity.
    Janda KD; Benkovic SJ; Lerner RA
    Science; 1989 Apr; 244(4903):437-40. PubMed ID: 2717936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Simple method for selecting catalytic monoclonal antibodies that exhibit turnover and specificity.
    Tawfik DS; Zemel RR; Arad-Yellin R; Green BS; Eshhar Z
    Biochemistry; 1990 Oct; 29(42):9916-21. PubMed ID: 2271630
    [TBL] [Abstract][Full Text] [Related]  

  • 12. catELISA: a facile general route to catalytic antibodies.
    Tawfik DS; Green BS; Chap R; Sela M; Eshhar Z
    Proc Natl Acad Sci U S A; 1993 Jan; 90(2):373-7. PubMed ID: 7678455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Catalytic antibodies induced by a zwitterionic hapten.
    Tsumuraya T; Takazawa N; Tsunakawa A; Fleck R; Masamune S
    Chemistry; 2001 Sep; 7(17):3748-55. PubMed ID: 11575776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Catalytic antibodies that hydrolyze (-)-cocaine obtained by a high-throughput procedure.
    Cashman JR; Berkman CE; Underiner GE
    J Pharmacol Exp Ther; 2000 Jun; 293(3):952-61. PubMed ID: 10869397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New strategies for the design of catalytic antibodies.
    Janda KD
    Biotechnol Prog; 1990; 6(3):178-81. PubMed ID: 1366610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polyclonal antibody preparation with Michaelian catalytic properties.
    Gallacher G; Jackson CS; Searcey M; Badman GT; Goel R; Topham CM; Mellor GW; Brocklehurst K
    Biochem J; 1991 Nov; 279 ( Pt 3)(Pt 3):871-81. PubMed ID: 1953683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design of biomimetic catalysts by molecular imprinting in synthetic polymers: the role of transition state stabilization.
    Wulff G; Liu J
    Acc Chem Res; 2012 Feb; 45(2):239-47. PubMed ID: 21967389
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of a general base mechanism for ester hydrolysis in C-C hydrolase enzymes of the alpha/beta-hydrolase superfamily: a novel mechanism for the serine catalytic triad.
    Li JJ; Bugg TD
    Org Biomol Chem; 2007 Feb; 5(3):507-13. PubMed ID: 17252134
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism-based catalytic antibody inactivation.
    Angeles TS; Martin MT
    Biochem Biophys Res Commun; 1993 Dec; 197(2):696-701. PubMed ID: 8267606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for antibody catalysis of a disfavored ring closure reaction.
    Gruber K; Zhou B; Houk KN; Lerner RA; Shevlin CG; Wilson IA
    Biochemistry; 1999 Jun; 38(22):7062-74. PubMed ID: 10353817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.